PTAB Sees No Overlap In Rival Schools' Gene-Editing Patents

By Suevon Lee (February 15, 2017, 9:17 PM EST) -- A genomic research center affiliated with the Massachusetts Institute of Technology and Harvard University scored a key win involving its patents on groundbreaking gene-editing technology when the Patent Trial and Appeal Board said Wednesday that the patents don't interfere with claims filed by a rival research team.

The per curiam ruling delivered the threshold finding that the Cambridge, Massachusetts-based Broad Institute's gene-editing technology known as CRISPR contains patentably distinct subject matter from technology invented by a team of scientists from the University of California, Berkeley, and the University of Vienna.

The judgment of "no interference in fact" in a special inter...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!